Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06154161 · ClinicalTrials.gov registry record · NA
Examining the Impact of High-protein Oral Supplement on Protein Status of Adults on Peritoneal Dialysis
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06154161: Completed NA study, sponsored by University of Florida.
NCT06154161 is a NA study that has completed, run by University of Florida. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06154161, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a 6-month prospective interventional clinical trial designed to evaluate the impact of whey protein isolate oral supplement on protein status. Differences in protein status will be evaluated with review of the medical chart from standard of care monthly blood collection for serum albumin, total protein, and normalized protein catabolic rate (nPCR) as detected by serum urea nitrogen. Mid-arm circumference and weight will be measured to ensure no significant changes. Quality of life will be measured to detect if the addition of protein aided in overall quality of life. There will be a 3-month recruitment period prior to the start of the trial to ensure the potential participants are familiarized with the clinical trial. After the recruitment period has finished, eligible participants will sign the consent form in order to participate in the study. At this point, participants will be provided the supplements for the month and instructed with the amount of water and how to mix with the provided measuring and drinking cup.
Primary Outcome
Collection of serum albumin to identify a change from pre-post to analyze the effect protein isolate had on inflammation marker and protein status.
Interventions
- DIETARY_SUPPLEMENT Whey protein supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
What the finished NCT06154161 record still lists
NCT06154161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Whey protein supplement is the first listed.
NCT06154161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06154161 about?
NCT06154161 is a clinical study titled "Examining the Impact of High-protein Oral Supplement on Protein Status of Adults on Peritoneal Dialysis". This is a 6-month prospective interventional clinical trial designed to evaluate the impact of whey protein isolate oral supplement on protein status. Differences in protein status will be evaluated with review of the medical chart from standard of care monthly blood collection for serum albumin, to...
What is the current status of trial NCT06154161?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2024-03-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT06154161?
The interventions under investigation include: Whey protein supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06154161?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06154161's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI